"There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence.

Lisa M ParkerAlexandra BennettBarbara MintzesQuinn GrundyAlice FabbriEmily A KarangesLisa Bero

Published in: British journal of clinical pharmacology (2020)

Improved DTC practices and review of hospital policies concerning pharmaceutical marketing activities might preserve the independence of evidence-based decision-making for safe, cost-effective prescribing.

Keyphrases

adverse drug
primary care
decision making
healthcare
public health
small molecule
drug induced